Kriya Therapeutics (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- May 17, 2022
- Vertical
- Gene Therapy
- Funding URL
- View Funding Page
- Funding Amount:
- $270,000,000
Company Info
- Founders
- Shankar Ramaswamy
- Company Description
- Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.
- Market
- Healthcare
- Location
- Redwood City, California, USA
- Coinvestors
- Bluebird Ventures, CAM Capital, Dexcel Pharma, Foresite Capital, JDRF T1D Fund, Lightswitch Capital, Narya, Patient Square Capital, QVT Financial, Transhuman Capital